Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigusDario Didona, Michael Hertl, Shu-Hung Wang et al.|British Journal of Dermatology|2025Cited by 5
LB1798 Tolerance induction in a preclinical pemphigus vulgaris (PV) mouse model utilizing desmoglein 3 peptides-conjugated nanoparticlesChristoph Hudemann, Holger Garn, B. Metzler et al.|Journal of Investigative Dermatology|2023Cited by 0